Literature DB >> 15894222

Genotypic guidance for chemotherapy choices.

Jane Bradbury.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15894222     DOI: 10.1016/S1359-6446(05)03435-5

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  1 in total

1.  Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach.

Authors:  Janice M Mehnert; Antoinette R Tan; Rebecca Moss; Elizabeth Poplin; Mark N Stein; Mika Sovak; Kelly Levinson; Hongxia Lin; Michael Kane; Murugesan Gounder; Yong Lin; Weichung Joe Shih; Eileen White; Eric H Rubin; Vassiliki Karantza
Journal:  Mol Cancer Ther       Date:  2011-06-16       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.